Brigit Biofarmaka Teknologi Tbk. vs Palma Serasih Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 37.4K 24h volume), while Palma Serasih Tbk. trades at Rp194 (market cap 3.68T, 106.7K 24h volume). The key difference: Palma Serasih Tbk. is far larger — about 22.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Palma Serasih Tbk. is more actively traded (106.7K versus 37.4K). Which is the better fit depends on your goals.
| OBAT | PSGO | |
|---|---|---|
Market Cap | 164.65B | 3.68T |
Volume | 37.4K | 106.7K |
Lot | 374 | 1.07K |
Turnover | 9.04M | 20.81M |
Average Price | 241.68 | 195.02 |
Value | 9.04M | 20.81M |
Indicative Equilibrium Price | 238 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT. Palma Serasih Tbk (the Company) was established in Jakarta based on Notarial Deed of Besri Zakaria,S.H. No.1 dated June 3, 2008. PT Jalinan kasih Sesama is the parent entity and the ultimate parent entity of the Group.
Read more on PSGO →